Volume 189 - Issue 1
Misleading advertising of PI-based drug information?
Author: Jim R Stockigt
Med J Aust 2008; 189 (1): 56. || doi: 10.5694/j.1326-5377.2008.tb01913.x
Published online: 7 July 2008
Published online: 7 July 2008
Re: “Misleading advertising of PI-based drug information?”, the letter by Jim R Stockigt, in the printed version of the 2 June 2008 issue of the Journal (Med J Aust 2008; 188: 679-680). Professor Stockigt’s affiliations were incorrect and incomplete, and should have read:
Gabapentinoid Poisoning Presentations to Victorian Emergency Departments: A 15-Year Trend Analysis
Bishaal Tej Gurung, Amy McNeilage, Angus Skeen, Tina Lam, Joanna F. Dipnall, Jane Hayman, Suzanne Nielsen, Ting Xia
Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild-to-Moderate COVID-19 Cases in a Broadly Immune Population
Hadar Mudrik-Zohar, Tim Cutfield, Susan Morpeth, Thomas Hills, Eamon Duffy, Laura J. Edwards, Allen C. Cheng, Steven Y. C. Tong
Birth prevalence, clinical sequelae, and management of congenital cytomegalovirus infections in Australia, 1999–2023: a national prospective study
Ece Egilmezer, Suzy M Teutsch, Carlos Nunez, Stuart T Hamilton, Adam W Bartlett, Pamela Palasanthiran, Elizabeth J Elliott, William D Rawlinson
Concurrent use of hormonal long‐acting reversible contraception by women of reproductive age dispensed teratogenic medications, Australia, 2013–2021
Aaron E Boyce, Tony Caccetta, Jo‐Ann See, Rosemary L Nixon AM
Concurrent use of hormonal long‐acting reversible contraception by women of reproductive age dispensed teratogenic medications, Australia, 2013–2021
Michelle KY Chen, Adrian Lim, Deshan F Sebaratnam
Medication delivery and dispensing interval preferences of people who use antihypertensive medications in Australia: a survey study
Carissa Bonner, Michael A Fajardo, Rachael M Keast, Emily Atkins, Niamh Chapman, Kristie R Weir, Anthony Rodgers, Aletta E Schutte